The average one-year price target for Beta Bionics (NasdaqGM:BBNX) has been revised to $31.93 / share. This is an increase of 23.23% from the prior estimate of $25.91 dated November 7, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $23.23 to a high of $36.75 / share. The average price target represents an increase of 17.46% from the latest reported closing price of $27.18 / share.
What is the Fund Sentiment?
There are 233 funds or institutions reporting positions in Beta Bionics. This is an increase of 3 owner(s) or 1.30% in the last quarter. Average portfolio weight of all funds dedicated to BBNX is 0.37%, an increase of 2.06%. Total shares owned by institutions increased in the last three months by 11.62% to 51,319K shares.
What are Other Shareholders Doing?
Eventide Asset Management holds 4,957K shares representing 11.26% ownership of the company. In its prior filing, the firm reported owning 4,932K shares , representing an increase of 0.50%. The firm increased its portfolio allocation in BBNX by 28.69% over the last quarter.
Farallon Capital Management holds 4,314K shares representing 9.80% ownership of the company. In its prior filing, the firm reported owning 4,204K shares , representing an increase of 2.55%. The firm increased its portfolio allocation in BBNX by 32.87% over the last quarter.
Wellington Management Group Llp holds 3,902K shares representing 8.86% ownership of the company. No change in the last quarter.
Soleus Capital Management holds 3,870K shares representing 8.79% ownership of the company. In its prior filing, the firm reported owning 3,820K shares , representing an increase of 1.29%. The firm increased its portfolio allocation in BBNX by 5.10% over the last quarter.
Sands Capital Ventures holds 3,570K shares representing 8.11% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
